Hyman Charles D Danaher Corp Transaction History

Hyman Charles D

$1.79 Billion
Q2 2024

A detailed history of Hyman Charles D transactions in Danaher Corp stock. As of the latest transaction made, Hyman Charles D holds 7,736 shares of DHR stock, worth $1.47 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

7,736

Previous 7,736 -0.0%

Holding current value

$1.47 Million

Previous $1.93 Million 0.05%

% of portfolio

0.11%

Previous 0.11%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$239.75 - $277.0 $191,560 - $221,323	799 Added 11.52%	7,736 $1.95 Million
Q3 2022 Nov 09, 2022	BUY	$247.06 - $1507.4 $2,717 - $16,581	11 Added 0.16%	6,937 $1.79 Million
Q2 2022 Aug 02, 2022	BUY	$237.11 - $299.66 $71,133 - $89,898	300 Added 4.53%	6,926 $1.76 Million
Q3 2021 Nov 09, 2021	BUY	$272.21 - $332.43 $9,799 - $11,967	36 Added 0.55%	6,626 $2.02 Million
Q2 2021 Aug 05, 2021	BUY	$225.08 - $271.69 $78,778 - $95,091	350 Added 5.61%	6,590 $1.77 Million
Q1 2021 Apr 28, 2021	SELL	$212.38 - $245.9 $3,822 - $4,426	-18 Reduced 0.29%	6,240 $1.4 Million
Q4 2020 Feb 08, 2021	SELL	$212.5 - $245.46 $18,487 - $21,355	-87 Reduced 1.37%	6,258 $1.39 Million
Q3 2020 Oct 26, 2020	SELL	$177.16 - $215.33 $9,389 - $11,412	-53 Reduced 0.83%	6,345 $1.37 Million
Q2 2020 Aug 06, 2020	BUY	$128.7 - $176.83 $559,201 - $768,326	4,345 Added 211.64%	6,398 $1.13 Million
Q1 2020 Apr 30, 2020	BUY	$121.39 - $169.05 $19,179 - $26,709	158 Added 8.34%	2,053 $284,000
Q4 2019 Feb 03, 2020	SELL	$133.47 - $153.48 $4,671 - $5,371	-35 Reduced 1.81%	1,895 $291,000
Q3 2019 Nov 07, 2019	SELL	$135.4 - $146.47 $47,796 - $51,703	-353 Reduced 15.46%	1,930 $279,000
Q2 2019 Jul 24, 2019	BUY	$124.88 - $143.73 $285,101 - $328,135	2,283 New	2,283 $326,000

Others Institutions Holding DHR

# of Institutions

2,501

Shares Held

559M

Call Options Held

6.75M

Put Options Held

3.37M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $138B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Account